Complete Ozempic vs Wegovy vs Mounjaro Stock Availability
Ozempic vs Wegovy vs Mounjaro: Current UK Stock Status
The availability landscape for weight management injections has been challenging across the UK, making the Ozempic vs Wegovy vs Mounjaro decision even more complex. Ozempic, whilst containing the same active ingredient as Wegovy (semaglutide), is licensed exclusively for type 2 diabetes treatment in the UK. Prescribing or promoting Wegovy for weight management constitutes illegal off-label advertising, leaving patients with two primary options: Wegovy and Mounjaro.
At EverydayMeds, we maintain comprehensive stock levels of all five Wegovy doses (0.25mg through 2.4mg) sourced directly from Novo Nordisk's UK supply chain. Our reliable inventory management ensures patients can progress through their dose escalation schedule without interruption. This consistent availability addresses one of the most significant concerns in the Ozempic vs Wegovy vs Mounjaro comparison: reliable access to treatment throughout your weight management journey.
Wegovy vs Mounjaro Pricing: Complete Cost Breakdown
When comparing Ozempic vs Wegovy vs Mounjaro costs, it's essential to understand that Ozempic pricing is irrelevant for weight management as it cannot be legally prescribed for this purpose. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout to achieve these final prices, whilst returning customers use code DOSE25.
Our bundle options provide convenient multi-month supplies without multiple orders. The Intro Trio (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first three months of treatment. For maintenance patients, the Ultimate Stability Trio provides three 2.4mg pens for £649.99, ensuring consistent supply at the therapeutic dose. Mounjaro pricing varies by dose similarly, though both medicines require the same thorough clinical assessment and prescriber review process.
Clinical Evidence: Ozempic vs Wegovy vs Mounjaro Research
The clinical evidence supporting these medicines varies significantly in the Ozempic vs Wegovy vs Mounjaro comparison. Ozempic's trials focused on glycaemic control in diabetes, not weight management outcomes. Wegovy's evidence comes from the comprehensive STEP trial programme, including STEP 1 which demonstrated average weight loss of approximately 15% at 68 weeks versus 2.4% with placebo, as reported by Wilding et al. in NEJM, 2021.
Mounjaro's evidence derives from the SURMOUNT trials, showing the potential benefits of its dual GIP and GLP-1 receptor agonism. However, comparing weight loss percentages directly between Wegovy and Mounjaro trials isn't appropriate due to different study designs, patient populations, and endpoints. Both medicines are available from EverydayMeds, and your prescriber can help determine which mechanism may be most suitable for your individual circumstances.
How Wegovy Works in the Ozempic vs Wegovy vs Mounjaro Context
Understanding the mechanisms helps clarify the Ozempic vs Wegovy vs Mounjaro comparison. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This hormone signals to your brain's appetite centres, potentially reducing hunger and promoting satiety after smaller meals. The medicine may also slow gastric emptying, helping you feel satisfied for longer periods. Additionally, Wegovy can influence food cravings by acting on reward pathways in the brain. These mechanisms work alongside a reduced-calorie diet and increased physical activity to support sustainable weight management outcomes.
Streamlined Ordering Process for All Stock Items
Our ordering process eliminates the complexity often associated with the Ozempic vs Wegovy vs Mounjaro decision-making journey. Begin with our 3-minute online clinical assessment, designed to gather essential medical history and current health information. Your assessment undergoes review by our qualified prescribers within 3 working days (or 24 hours with express service). Once approved, your prescription-only medicine ships via next-day delivery using our temperature-controlled cold-chain system. This process applies equally whether you're starting Wegovy or considering Mounjaro, ensuring consistent access to your chosen treatment. Our GPhC-registered pharmacy (#9012878) maintains the highest standards for prescription medicine handling and patient care.
Storage and Practical Considerations
Storage requirements represent a practical differentiator in the Ozempic vs Wegovy vs Mounjaro comparison. Wegovy must be stored in the fridge at 2-8°C before first use, but can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration. This provides significant convenience for travel or daily use compared to Mounjaro's 21-day room temperature limit. Both medicines utilise pre-filled injection pens (FlexTouch for Wegovy), eliminating the need for online pharmacy dosing preparation. The dose escalation schedule requires careful progression through increasing strengths over 16 weeks to reach the maintenance dose. Missing doses or attempting to skip escalation steps can increase the risk of gastrointestinal side effects and reduce treatment effectiveness.
UK Market Availability: Why Stock Matters for Treatment Success
The UK weight management injection market has experienced significant supply constraints, making the Ozempic vs Wegovy vs Mounjaro availability question crucial for treatment continuity. Many patients have faced interruptions in their dose escalation schedules due to stock shortages, potentially compromising treatment outcomes. EverydayMeds' commitment to maintaining comprehensive stock levels ensures patients can complete their full titration schedule without gaps. This reliability becomes particularly important during the initial 16-week escalation period, where missed doses can necessitate restarting at lower strengths.
Our direct relationships with Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro) enable consistent supply forecasting and inventory management. Unlike some providers who may only stock popular doses, we maintain full ranges to support patients at every stage of treatment. This comprehensive availability removes the stress of hunting for specific doses across multiple pharmacies, allowing you to focus on your weight management goals rather than supply logistics.
Making Your Decision: Expert Support and Next Steps
The Ozempic vs Wegovy vs Mounjaro choice ultimately depends on your individual medical profile, with Ozempic eliminated from weight management consideration due to licensing restrictions. Our clinical team provides expert guidance during the assessment process, considering factors like your medical history, current medications, and treatment goals. Wegovy's established evidence base and 6-week room temperature stability may suit some patients, whilst Mounjaro's dual hormone mechanism appeals to others. Both medicines are available from EverydayMeds with identical ordering, prescription, and delivery processes. Start your clinical assessment today using code FIRST40 for new customer pricing, or browse our full range at https://everydaymeds.co.uk/collections/wegovy. Your prescriber will help determine which option aligns best with your weight management objectives and medical circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
